ACADIA PHARMACEUTICALS INC. Other Noncash Income (Expense)
ACADIA PHARMACEUTICALS INC. (ACAD) reported Other Noncash Income (Expense) of $10.00 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2014-05-06
- ACADIA PHARMACEUTICALS INC. other noncash income (expense) for the quarter ending 2013-09-30 was $23.00K, a 88.94% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. other noncash income (expense) for the quarter ending 2013-06-30 was -$20.00K, a 157.14% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. other noncash income (expense) for the quarter ending 2013-03-31 was $7.00K, a 22.22% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. other noncash income (expense) for the quarter ending 2012-09-30 was $208.00K.
- ACADIA PHARMACEUTICALS INC. other noncash income (expense) for fiscal 2010 was $94.00K.
- ACADIA PHARMACEUTICALS INC. other noncash income (expense) for fiscal 2009 was -$323.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2013-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $3.00K derived: sum of 2 quarters · filed 2013-11-06 | $10.00K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$13.00K 10-Q · filed 2013-08-06 | ||
| 2013-03-31 | $7.00K 10-Q · filed 2014-05-06 | |||
| 2012-09-30 | $208.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $243.00K derived: sum of 2 quarters · filed 2013-11-06 | $252.00K 10-Q · filed 2013-11-06 | |
| 2012-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $44.00K 10-Q · filed 2013-08-06 | ||
| 2012-03-31 | $9.00K 10-Q · filed 2012-05-08 | |||
| 2011-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$241.00K 10-Q · filed 2011-11-09 | ||
| 2011-06-30 | -$219.00K 10-Q · filed 2011-08-10 | |||
| 2010-12-31 | -$202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-06 | -$150.00K derived: sum of 2 quarters · filed 2012-03-06 | $94.00K 10-K · filed 2012-03-06 | |
| 2010-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $296.00K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $244.00K 10-Q · filed 2011-08-10 | |||
| 2009-12-31 | -$323.00K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |